Key result
Acute ischemic stroke during ACS is linked to ~354% higher in-hospital mortality without altering troponin.
Why the study?
Does the presence of acute ischemic stroke affect serum cardiac troponin I levels in patients with acute coronary syndrome?
Observational (n=138)
No
Does the presence of acute ischemic stroke affect serum cardiac troponin I levels in patients with acute coronary syndrome?
Effect estimate: OR 4.540 (95% CI 1.76-11.74)
Absolute Event Rate: 31.7% vs 9.3%
p-value: p=0.002
In patients with ACS, concomitant acute ischemic stroke does not significantly alter serum troponin I levels, suggesting abnormal troponin is primarily of cardiac origin.
Troponin I remains interpretable for ACS despite stroke; confirms cardiac origin while leaving mortality mechanisms open.
BACKGROUND AND PURPOSE: Cardiac troponin I (cTnI) is a reliable marker to diagnose acute myocardial infarction, but the pathophysiological explanation for the increase in cTnI levels in patients with acute ischemic stroke (IS) remains unknown. To overcome this question, we aimed to compare serum cTnI levels in acute coronary syndrome (ACS) concomitant with and without stroke. By doing like this, we thought that we could demonstrate the effect of stroke on TrpI level. METHODS: Serum cTnI levels of 41 patients having ACS with acute IS during hospitalization were compared with 97 control patients having only ACS. Cranial CT was performed to evaluate the lesions. The severity of IS was evaluated objectively by national institutes of health stroke scale. RESULTS: cTnI levels were found to be similar in both groups. Presence of diabetes mellitus, coronary artery disease and previous myocardial infarction were more frequent in patients with acute IS. The cTnI levels in the patients with the cranial lesion in the anterior circulation was higher (p = 0.039). Presence of acute IS, cTnI level higher than 20 ng/mL and left ventricular ejection fraction < 40% were found to be independent risk factors for mortality (p < 0.05). CONCLUSIONS: We found that abnormal troponin levels were more likely to be due to cardiac causes than cerebral ones in this first study evaluating the cTnI levels in patients with ACS concomitant with acute IS. The severity of IS, lesion location in the anterior circulation and higher troponin levels were associated with mortality.
No takes yet. Share an insight, caveat, or question.
Yıldız et al. (2018) conducted an observational in Acute coronary syndrome with or without acute ischemic stroke (n=138). Concomitant acute ischemic stroke vs. Acute coronary syndrome alone was evaluated on In-hospital mortality (OR 4.540, 95% CI 1.76-11.74, p=0.002). In patients with acute coronary syndrome, concomitant acute ischemic stroke did not significantly alter serum troponin I levels but significantly increased in-hospital mortality (OR 4.540).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: